DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
16.34
-0.29 (-1.71%)
Jul 11, 2025, 9:39 AM - Market open
DENTSPLY SIRONA Revenue
DENTSPLY SIRONA had revenue of $879.00M in the quarter ending March 31, 2025, a decrease of -7.76%. This brings the company's revenue in the last twelve months to $3.72B, down -5.61% year-over-year. In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%.
Revenue (ttm)
$3.72B
Revenue Growth
-5.61%
P/S Ratio
0.90
Revenue / Employee
$265,643
Employees
14,000
Market Cap
3.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
| Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
| Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
| Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
| Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
XRAY News
- 1 day ago - Dentsply Sirona to Host Second Quarter Conference Call on August 7th - GlobeNewsWire
- 23 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 25 days ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 weeks ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect - Accesswire
- 4 weeks ago - INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation - Accesswire
- 5 weeks ago - Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes - GlobeNewsWire